sodium tungstate(vi) has been researched along with Hyperglycemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertinat, R; Gatica, R; Nualart, F; Westermeier, F | 1 |
Altirriba, J; Barbera, A; Del Zotto, H; Gagliardino, JJ; Gomis, R; Nadal, B; Piquer, S; Sánchez-Pla, A | 1 |
Aslan, M; Aydemir, M; Dogan, S; Olgar, Y; Ozdemir, S; Ozturk, N | 1 |
Domínguez, J; Girón, MD; Guinovart, JJ; Salto, R; Sevillano, N; Vargas, AM | 1 |
1 review(s) available for sodium tungstate(vi) and Hyperglycemia
Article | Year |
---|---|
Sodium tungstate: Is it a safe option for a chronic disease setting, such as diabetes?
Topics: Blood Glucose; Chronic Disease; Diabetes Mellitus, Type 2; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Tungsten Compounds | 2018 |
3 other study(ies) available for sodium tungstate(vi) and Hyperglycemia
Article | Year |
---|---|
Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach.
Topics: Animals; Cell Proliferation; Diabetes Mellitus, Experimental; Gene Expression Profiling; Hyperglycemia; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Mitogen-Activated Protein Kinases; Oligonucleotide Array Sequence Analysis; Pancreas; Phlorhizin; Rats; Rats, Wistar; Streptozocin; Tungsten Compounds | 2009 |
Sodium tungstate administration ameliorated diabetes-induced electrical and contractile remodeling of rat heart without normalization of hyperglycemia.
Topics: Animals; Blood Glucose; Body Weight; Calcium; Calcium Channels, L-Type; Cardiotonic Agents; Diabetes Complications; Diabetes Mellitus, Experimental; Electrophysiological Phenomena; Heart; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Myocardial Contraction; Myocytes, Cardiac; Organ Size; Oxidative Stress; Patch-Clamp Techniques; Protein Carbonylation; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Tungsten Compounds; Xanthine Dehydrogenase; Xanthine Oxidase | 2012 |
The glucose-lowering agent sodium tungstate increases the levels and translocation of GLUT4 in L6 myotubes through a mechanism associated with ERK1/2 and MEF2D.
Topics: Animals; Cells, Cultured; Deoxyglucose; Glucose; Glucose Transporter Type 4; Hyperglycemia; MAP Kinase Signaling System; MEF2 Transcription Factors; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Skeletal; Myoblasts; Myogenic Regulatory Factors; Promoter Regions, Genetic; Rats; Transcription, Genetic; Transfection; Tritium; Tungsten Compounds | 2008 |